These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18360710)

  • 1. Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
    Bilir A; Erguven M; Oktem G; Ozdemir A; Uslu A; Aktas E; Bonavida B
    Int J Oncol; 2008 Apr; 32(4):829-39. PubMed ID: 18360710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol in glioma treatment alone and with imatinib in vitro.
    Erguven M; Yazihan N; Aktas E; Sabanci A; Li CJ; Oktem G; Bilir A
    Int J Oncol; 2010 Apr; 36(4):857-66. PubMed ID: 20198329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of imatinib at different concentrations on rat C6 glioma cell apoptosis and cell cycle].
    Yang L; Xu ZY; Chen XH; Wang KW; Li GF; Chen ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1089-91. PubMed ID: 20501402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of suramin on telomerase activity and spheroid growth of C6 glioma cells.
    Erguven M; Akev N; Ozdemir A; Karabulut E; Bilir A
    Med Sci Monit; 2008 Aug; 14(8):BR165-73. PubMed ID: 18667993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an imatinib-sensitive subset of high-grade human glioma cultures.
    Hägerstrand D; Hesselager G; Achterberg S; Wickenberg Bolin U; Kowanetz M; Kastemar M; Heldin CH; Isaksson A; Nistér M; Ostman A
    Oncogene; 2006 Aug; 25(35):4913-22. PubMed ID: 16547494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
    Weigel MT; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Bauer M; Jonat W; Maass N; Mundhenke C
    Cancer Lett; 2009 Jan; 273(1):70-9. PubMed ID: 18809244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
    Benny O; Menon LG; Ariel G; Goren E; Kim SK; Stewman C; Black PM; Carroll RS; Machluf M
    Clin Cancer Res; 2009 Feb; 15(4):1222-31. PubMed ID: 19190128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
    Rakshit S; Bagchi J; Mandal L; Paul K; Ganguly D; Bhattacharjee S; Ghosh M; Biswas N; Chaudhuri U; Bandyopadhyay S
    Apoptosis; 2009 Mar; 14(3):298-308. PubMed ID: 19153832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia.
    Mora R; Abschuetz A; Kees T; Dokic I; Joschko N; Kleber S; Geibig R; Mosconi E; Zentgraf H; Martin-Villalba A; Régnier-Vigouroux A
    Glia; 2009 Apr; 57(5):561-81. PubMed ID: 18942750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorimipramine: a novel anticancer agent with a mitochondrial target.
    Daley E; Wilkie D; Loesch A; Hargreaves IP; Kendall DA; Pilkington GJ; Bates TE
    Biochem Biophys Res Commun; 2005 Mar; 328(2):623-32. PubMed ID: 15694394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medroxyprogesterone acetate induces c6 glioma chemosensitization via antidepressant-like lysosomal phospholipidosis/myelinosis in vitro.
    Altinoz MA; Gedikoglu G; Sav A; Ozcan E; Ozdilli K; Bilir A; Del Maestro RF
    Int J Neurosci; 2007 Oct; 117(10):1465-80. PubMed ID: 17729157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib.
    Catalano MG; Pugliese M; Poli R; Bosco O; Bertieri R; Fortunati N; Boccuzzi G
    Oncol Rep; 2009 Feb; 21(2):515-21. PubMed ID: 19148530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells.
    Shingu T; Fujiwara K; Bögler O; Akiyama Y; Moritake K; Shinojima N; Tamada Y; Yokoyama T; Kondo S
    Int J Cancer; 2009 Mar; 124(5):1060-71. PubMed ID: 19048625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma.
    O'Reilly T; Wartmann M; Maira SM; Hattenberger M; Vaxelaire J; Muller M; Ferretti S; Buchdunger E; Altmann KH; McSheehy PMJ
    Cancer Chemother Pharmacol; 2005 Apr; 55(4):307-317. PubMed ID: 15723258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
    Jakubowska J; Wasowska-Lukawska M; Czyz M
    Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents.
    Yang JJ; Yin JH; Yang DI
    Neurosci Lett; 2007 May; 418(1):106-10. PubMed ID: 17412510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.
    Bertz J; Zang C; Liu H; Wächter M; Possinger K; Koeffler HP; Elstner E
    Leuk Res; 2009 May; 33(5):686-92. PubMed ID: 19131110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetraethylammonium inhibits glioma cells via increasing production of intracellular reactive oxygen species.
    Yang KB; Zhao SG; Liu YH; Hu EX; Liu BX
    Chemotherapy; 2009; 55(5):372-80. PubMed ID: 19707016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of vitamin D3-loaded nanoparticles to C6 glioma cell line increased resistance to doxorubicin, epirubicin, and docetaxel in vitro.
    Maleklou N; Allameh A; Kazemi B
    In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):989-1000. PubMed ID: 27503515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.